Effect of combined treatment with sub-Tenon injection of triamcinolone acetonide and photodynamic therapy in Japanese patients with age-related macular degeneration

Japanese Journal of Ophthalmology

Volumn 53, Issue 5, 2009, Pages 512-518

  Saito, Koko ^a,b   Yamamoto, Teiko ^b   Tsuchiya, Daijiro ^b   Kawasaki, Ryo ^b,c   Haneda, Shion ^b   Yamashita, Hidetoshi ^b  

^a Shinoda General Hospital   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Age related macular degeneration; Photodynamic therapy; Polypoidal choroidal vasculopathy; Sub Tenon injection; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE ACETONIDE; VERTEPORFIN;

ADULT; AGED; FEMALE; FOLLOW UP; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETREATMENT; REVIEW; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMBINED MODALITY THERAPY; CONNECTIVE TISSUE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; JAPAN; MACULAR DEGENERATION; MALE; PHOTOCHEMOTHERAPY; RETREATMENT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 77749289938     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-009-0703-6     Document Type: Review

References (30)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report Arch Ophthalmol 117 1329 1345
2. Verteporfin in Photodynamic Therapy 2001 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2 Am J Ophthalmol 131 541 560 10.1016/S0002-9394(01)00967-9 (Pubitemid 32427660)
3. Japanese Age-Related Macular Degeneration Trial 2003 Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 1049 1061 10.1016/S0002-9394(03)00576-2 (Pubitemid 37485771)
4. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy 2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2 Arch Ophthalmol 119 198 207
5. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy 2002 Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3 Arch Ophthalmol 120 1443 1454
6. R.F. Spaide J. Sorenson L. Maranan 2003 Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization Ophthalmology 110 1517 1525 10.1016/S0161-6420(03)00544-X 12917166 (Pubitemid 36962483)
7. E. Rechtman R.P. Danis L.M. Pratt A. Harris 2004 Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration Br J Ophthalmol 88 344 347 10.1136/bjo.2003.027177 1:STN:280:DC%2BD2c7ivF2itg%3D%3D 14977766 (Pubitemid 38333711)
8. R.F. Spaide J. Sorenson L. Maranan 2005 Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization Ophthalmology 112 301 304 10.1016/j.ophtha.2004.08. 012 15691567 (Pubitemid 40202568)
9. L. Arias J. Garcia-Arumi J.M. Ramon M. Badia M. Rubio O. Pujol 2006 Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study Ophthalmology 113 2243 2250 10.1016/j.ophtha.2006.04.039 16996600 (Pubitemid 44838921)
10. A.J. Augustin U. Schmidt-Erfurth 2006 Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration Am J Ophthalmol 141 638 645 10.1016/j.ajo.2005.11.058 1:CAS:528:DC%2BD28XivVaqtbY%3D 16564797
11. J.M. Ruiz-Moreno J.A. Montero S. Barile M.A. Zarbin 2006 Photodynamic therapy and high dose intravitreal triamcinolone to treat exudative age-related macular degeneration 1-year outcome Retina 26 602 612 10.1097/00006982- 200607000-00003 16829800 (Pubitemid 44620358)
12. A. Van de Moere S.S. Sandhu R. Kak K.W. Mitchell S.J. Talks 2005 Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin Ophthalmology 112 1896 1903 10.1016/j.ophtha.2005.06.018 16214216 (Pubitemid 41551916)
13. A. Iriyama R. Obata Y. Inoue H. Takahashi Y. Tamaki Y. Yanagi 2008 Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy Graefes Arch Clin Exp Ophthalmol 246 339 344 10.1007/s00417-007-0667-5 1:CAS:528:DC%2BD1cXhs1Olsr4%3D 17805556 (Pubitemid 351247982)
14. M.M. Gilson N.M. Bressler D.A. Jabs S.D. Solomon J.E. Thorne D.J. Wilson 2007 Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration Ophthalmology 114 1713 1721 10.1016/j.ophtha.2007.03.071 17822977 (Pubitemid 47332678)
15. K. Sho K. Takahashi H. Yamada, et al. 2003 Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 1392 1396 10.1001/archopht.121.10.1392 14557174 (Pubitemid 37243739)
16. I. Maruko T. Iida M. Saito D. Nagayama K. Saito 2007 Clinical characteristics of exudative age-related macular degeneration in Japanese patients Am J Ophthalmol 144 15 22 10.1016/j.ajo.2007.03.047 17509509 (Pubitemid 46963198)
17. Japanese Study Group of Polypoidal Choroidal Vasculopathy. 2005 Criteria for diagnosis of polypoidal choroidal vasculopathy [in Japanese] Nippon Ganka Gakkai Zasshi 109 417 427
18. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 2002;22:6-18.
19. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 2005;25:119-134.
20. M.L. Nelson M.T. Tennant A. Sivalingam C.D. Regillo J.B. Belmont A. Martidis 2003 Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection Retina 23 686 691 10.1097/00006982-200310000-00014 14574256 (Pubitemid 37315056)
21. J.M. Ruiz-Moreno J.A. Montero M.A. Zarbin 2007 Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome Retina 27 458 461 10.1097/IAE.0b013e318030c77c 17420698 (Pubitemid 46624286)
22. R.F. Spaide I. Donsoff D.L. Lam, et al. 2002 Treatment of polypoidal choroidal vasculopathy with photodynamic therapy Retina 22 529 535 10.1097/00006982-200210000-00001 12441716
23. W.M. Chan D.S. Lam T.Y. Lai, et al. 2004 Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 1576 1584 10.1016/j.ophtha.2003. 12.056 15288991 (Pubitemid 39030815)
24. S.C. Lee Y.S. Seong S.S. Kim H.J. Koh O.W. Kwon 2004 Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula Ophthalmologica 218 193 201 10.1159/000076844 1:CAS:528:DC%2BD2cXjt12rs7k%3D 15103216 (Pubitemid 38596586)
25. R.M. Silva J. Figueira M.L. Cachulo L. Duarte J.R. Faria de Abreu J.G. Cunha-Vaz 2005 Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 243 973 979 10.1007/s00417-005- 1139-4 1:CAS:528:DC%2BD2MXhtFart7fN 15864616 (Pubitemid 41631036)
26. W.M. Chan T.Y. Lai Y. Tano D.T. Liu K.K. Li D.S. Lam 2006 Photodynamic therapy in macular diseases of Asian populations: when East meets West Jpn J Ophthalmol 50 161 169 10.1007/s10384-005-0259-z 1:CAS:528:DC%2BD28XktFaqsro%3D 16604394
27. E. Akaza M. Yuzawa Y. Matsumoto S. Kashiwakura K. Fujita R. Mori 2007 Role of photodynamic therapy in polypoidal choroidal vasculopathy Jpn J Ophthalmol 51 270 277 10.1007/s10384-007-0452-3 17660987 (Pubitemid 47174610)
28. E. Akaza R. Mori M. Yuzawa 2008 Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy Retina 28 717 722 10.1097/IAE. 0b013e31816577cb 18463515 (Pubitemid 351655124)
29. T. Ogino M. Takeda H. Imaizumi U. Okushiba 2007 Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year Jpn J Ophthalmol 51 210 215 10.1007/s10384-007-0436-3 17554484 (Pubitemid 46889507)
30. F. Gomi M. Ohji K. Sayanagi, et al. 2008 One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 115 141 146 10.1016/j.ophtha.2007.02.031 17582498 (Pubitemid 350309415)